Protein S functional assay and kit therefor

Details Protein S functional assay and kit therefor Protein S functional assay and kit therefor

2005-02-15

2005-02-15

Saucier, Sandra (Department: 1651)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving blood clotting factor

Reexamination Certificate

active

06855509

ABSTRACT:
The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.

REFERENCES:
patent: 4622389 (1986-11-01), Nagasawa et al.
patent: 4692406 (1987-09-01), Becker et al.
patent: 4755461 (1988-07-01), Lawson et al.
patent: 4849403 (1989-07-01), Stocker et al.
patent: 5001069 (1991-03-01), Bartl et al.
patent: 5051357 (1991-09-01), Hassouna
patent: 5059525 (1991-10-01), Bartl et al.
patent: 5147805 (1992-09-01), Preda et al.
patent: 5169786 (1992-12-01), Carroll et al.
patent: 5187067 (1993-02-01), Koike et al.
patent: 5200322 (1993-04-01), Matsumoto
patent: 5223427 (1993-06-01), Edgington et al.
patent: 5254350 (1993-10-01), Barrow et al.
patent: 5270451 (1993-12-01), Hawkins et al.
patent: 5308756 (1994-05-01), van de Waart et al.
patent: 5314695 (1994-05-01), Brown
patent: 5358853 (1994-10-01), Butler et al.
patent: 5374617 (1994-12-01), Morrissey et al.
patent: 5391380 (1995-02-01), Barrow et al.
patent: 5418141 (1995-05-01), Zweig et al.
patent: 5426031 (1995-06-01), Hawkins et al.
patent: 5439802 (1995-08-01), Rosén
patent: 5443960 (1995-08-01), Dahlbäck
patent: 5472850 (1995-12-01), Morrissey
patent: 5502651 (1996-03-01), Jackson et al.
patent: 5504064 (1996-04-01), Morrissey et al.
patent: 5504067 (1996-04-01), Morrissey et al.
patent: 5506112 (1996-04-01), Lang et al.
patent: 5508170 (1996-04-01), Butler et al.
patent: 5525478 (1996-06-01), Matschiner
patent: 5643739 (1997-07-01), Varadi et al.
patent: 5705395 (1998-01-01), Griffin et al.
patent: 5716795 (1998-02-01), Matschiner
patent: 5726028 (1998-03-01), Kraus
patent: 5753510 (1998-05-01), Kraus
patent: 5766869 (1998-06-01), Arkel et al.
patent: 5780255 (1998-07-01), Preda
patent: 5834223 (1998-11-01), Griffin et al.
patent: 5858724 (1999-01-01), Novy, Jr. et al.
patent: 5874256 (1999-02-01), Bertina et al.
patent: 6040147 (2000-03-01), Ridker et al.
patent: 6083757 (2000-07-01), Griffin et al.
patent: 6090570 (2000-07-01), Kraus
patent: 6100072 (2000-08-01), Brucato et al.
patent: 6203816 (2001-03-01), Brown
patent: 6211344 (2001-04-01), Kraus et al.
patent: 2037434 (1991-09-01), None
patent: A 0 229 234 (1987-07-01), None
patent: 0 406 971 (1991-01-01), None
patent: 0 445 626 (1991-09-01), None
patent: 286323 (1993-12-01), None
patent: 434377 (1995-08-01), None
patent: 0 696 642 (1996-02-01), None
patent: 8807543 (1988-10-01), None
patent: 9011368 (1990-10-01), None
patent: 9101382 (1991-02-01), None
patent: 9101383 (1991-02-01), None
patent: 9102812 (1991-03-01), None
patent: 9208479 (1992-05-01), None
patent: 9307492 (1993-04-01), None
patent: 9310261 (1993-05-01), None
patent: 9313211 (1993-07-01), None
patent: 9323074 (1993-11-01), None
Madden et al., “Recombinant human protein C: comparative functional studies with human plasma protein C”, Trhombosis Research 57 (3) : 425-35 (1990).*
Almasy et al. “Linkage of the Factor V Gene with Protein C and Protein S Levels Not Due to the Factor V Leiden Mutation”,Washington, p. 387, (1999).
Amer et al. “Impairment of the Protein C Anticoagulant Pathway in a Patient with Systemic Lupus Erythematosus, Anticardiolipin Antibodies and Thrombosis,”Thrombosis Research, 57:247-258 (1990).
Amiral et al. “New Direct Assay of Free Protein S Antigen Using Two Distinct Monoclonal Antibodies Specific for the Free Form,”Blood Coag. and Fibrin., 5:179-186 (1994).
Andrews et al. “Conservation of Tissue Factor Primary Sequence Among Three Mammalian Species,”Gene, 98:265-269 (1991).
Bader et al. “Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids,”Thromb. Haemost., 71(3):292-299 (1994).
Baele et al. “Comparison of a Recombinant Thromboplastin with Thrombotest™ for Oral Anticoagulant Control,”Haemost., 26:11-15 (1996).
Bauer. “Hypercoaguability-A New Cofactor in the Protein C Anticoagulant Pathway,”New England Journal of Medicine, 330:566-567 (1994).
Beauchamp at al. “High Prevalence of a Mutation in the Factor V Gene Within the U.K. Population: Relationship to Activated Protein C Resistance and Familial Thrombosis,”British J. of Haemost., 88:219-222 (1994).
Bertina et al. “Mutation in Blood Coagulation Factor V Associated with Resistance to Activated Protein C,”Nature, 369:64-67 (1994).
Boyer-Neumann et al. “Comparison of Functional Assays for Protein S: European Collaborative Study of Patients with Congenital and Acquired Deficiency,”Thomb. and Haemost., 70(6):946-950 (1993).
Blangero et al. “Normal Activated Protein C Response has a Large Genetic Component,”Florencia, PS.920, p. 226, (Jun. 9, 1997).
Blangero et al. “Genetic Factors Influence Quantitative Variation in Tissue Factor Pathway Inhibitor,”Florencia, PS-1666, p. 409, (1997).
Blombäck et al. “Chromogenic Peptide Substrates in the Laboratory.Diagnosis of Clotting Disorders,”Haemostasis and Thrombosis, Bloom and Thomas (eds.), 2nded, 967-981 (1987).
Cattaneo. “Hyperhomocysteinemia, Atherosclerosis and Thrombosis,”Thromb. Haemost., 81:165-176 (1999).
Chromogenix, Coatest APC Resistance Kit Instructions, May 1993.
Chromogenix, Coatest APC Resistance Kit Brochure, Jun. 1993.
Comp. “Laboratory Evaluation of Protein S Status,”Seminars in Thromb. and Haemost., 16(2)177-181 (1990).
CornilIon et al. “Rat Coagulation Factor V Purification and Production of the Monospecific Antiserum,”Comp. Biochem. Physiol., 83B, 2: 397-401 (1986).
Cripe et al. “Structure of the Gene for Human Coagulation Factor V,”Biochemistry, 31: 3777-3785 (1992).
DahIbäck et al. “Resistance to Activated Protein C, the FV:Q506Allele, and Venous Thrombosis,”Ann. Hematol., 72:166-176 (1996).
Dahlbäck, “New Molecular Insights into the Genetics of Thrombophilia. Resistance to Activated Protein C Caused by Arg506to Gln Mutation in Factor V as a Pathogenic Risk Factor for Venous Thrombosis,”Thromb. Haemost., 74(1):139-148 (1995).
Dahlbäck. “Factor V Gene Mutation Causing Inherited Resistance to Activated Protein C as a Basis for Venous Thromboembolism,”J. Intern. Med., 237:221-227 (1995).
Dahlbäck et al. “Inherited Resistance to Activated Protein C is Corrected by Anticoagulant Cofactor Activity Found to be a Property of Factor V,”Proc. NatI. Acad. Sci.(USA), 91:1396-1400 (1994).
Dahlbäck. “A New Model for Coagulation Factor V Suggesting a Unique Mechanism of Activation,”Scand. J. Clin. Lab. Invest., 48, Suppl.191:47-61 (1988).
Dahlbäck. “Factor VIII Defect Associated with Familial Thrombophilia,”Thrombosis&Haemostatis, 65, Abstract 39:658 (1991).
Dahlbäck et al. “Familial Thrombophilia Due to a Previously Unrecognized Mechanism Characterized by Poor Anticoagulant Response to Activated Protein C: Prediction of a Cofactor to Activated Protein C,”Proc. Natl. Acad. Sci. USA, 90:1004-1008 (1993).
Dahlbäck. “Thrombophilia: The Discovery of Activated Protein C Resistance,”Advances in Genetics: Incorporating Molecular Genetic Medicine, Academic Press, (Hall et al. eds.), 135-175 (1995).
Dahlbäck et al. “A Natural Anticoagulant Pathway: Proteins C, S, C4b-Binding Protein an Thrombomodulin,”Haemostasis and Thrombosis(Bloom et al. eds.), 3rdedition, Churchill Livingstone, 671-698 (1994).
Dahlbäck. “The Protein C Anticoagulant System: Inherited Defects as Basis for Venous Thrombosis,”Thrombosis Research, 77:1-43

Affiliated with

Also associated with

Rating

Protein S functional assay and kit therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein S functional assay and kit therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein S functional assay and kit therefor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3497079